Emodin inhibits LOVO colorectal cancer cell proliferation via the regulation of the Bcl-2/Bax ratio and cytochrome c

Experimental and Therapeutic Medicine

Volumn 8, Issue 4, 2014, Pages 1225-1228

  Ma, Liang ^a   Li, Wusheng ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

B cell lymphoma 2; B cell lymphoma 2 associated x protein; Cell proliferation; Cytochrome c; Emodin

Indexed keywords

CYTOCHROME C; EMODIN; PROTEIN BAX; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY ASSAY; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; METABOLIC REGULATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

EID: 84906495730     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1900     Document Type: Article

References (19)

1. Ma YS, Weng SW, Lin MW, et al: Antitumor effects of emodin on LS1034 human colon cancer cells in vitro and in vivo: roles of apoptotic cell death and LS1034 tumor xenografts model. Food Chem Toxicol 50: 1271-1278, 2012.
2. Jing X, Ueki N, Cheng J, Imanishi H and Hada T: Induction of apoptosis in hepatocellular carcinoma cell lines by emodin. Jpn J Cancer Res 93: 874-882, 2002.
3. Liu A, Chen H, Wei W, et al: Antiproliferative and antimetastatic effects of emodin on human pancreatic cancer. Oncol Rep 26: 81-89, 2011.
4. Li J, Liu P, Mao H, Wanga A and Zhang X: Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro. Oncol Rep 21: 1605-1610, 2009.
5. Ko JC, Su YJ, Lin ST, et al: Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells. Biochem Pharmacol 79: 655-664, 2010.
6. Wang CG, Yang JQ, Liu BZ, et al: Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. Eur J Pharmacol 627: 33-41, 2010.
7. Shang T, Joseph J, Hillard CJ and Kalyanaraman B: Death-associated protein kinase as a sensor of mitochondrial membrane potential: role of lysosome in mitochondrial toxin-induced cell death. J Biol Chem 280: 34644-34653, 2005.
8. Bae JH, Park JW and Kwon TK: Ruthenium red, inhibitor of mitochondrial Ca2+ uniporter, inhibits curcumin-induced apoptosis via the prevention of intracellular Ca2+ depletion and cytochrome c release. Biochem Biophys Res Commun 303: 1073-1079, 2003.
9. Grishko V, Rachek L, Musiyenko S, Ledoux SP and Wilson GL: Involvement of mtDNA damage in free fatty acid-induced apoptosis. Free Radic Biol Med 38: 755-762, 2005.
10. Xu JD, Liu S, Wang W, et al: Emodin induces chloride secretion in rat distal colon through activation of mast cells and enteric neurons. Br J Pharmacol 165: 197-207, 2012.
11. Chen H, Wei W, Guo Y, et al: Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis. Oncol Rep 25: 1253-1261, 2011.
12. Reed JC: Bcl-2 family proteins. Oncogene 17: 3225-3236, 1998.
13. Wang JB, Qi LL, Zheng SD and Wu TX: Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J Zhejiang Univ Sci B 10: 93-102, 2009.
14. Pettersson F, Dalgleish AG, Bissonnette RP and Colston KW: Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br J Cancer 87: 555-561, 2002.
15. Wang X: The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933, 2001.
16. Wang YX, Yu H, Zhang YY, et al: Emodin induces apoptosis of human cervical cancer HeLa cells via intrinsic mitochondrial and extrinsic death receptor pathway. Cancer Cell Int 13: 71, 2013.
17. Guo LD, Chen XJ, Hu YH, Yu ZJ, Wang D, Liu JZ: Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway. Phytother Res: 27: 422-430, 2013.
18. Jin P, Wu ZT, Li SR, Li SJ, Wang JH, Wang ZH, Lu JG, Cui XJ, Han Y, Rao J, Sheng JQ: Colorectal cancer screening with fecal occult blood test: A 22-year cohort study. Oncol Lett 6: 576-582, 2013.
19. Andre T, Boni C, Mounedji-Boudiaf L: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med: 350: 2343-2351, 2004.